Skip to main content
OpenTrials

Clinical trial condition

Prostatic Neoplasms

Explore clinical trials studying Prostatic Neoplasms. Study availability and eligibility vary by location and protocol.

322 public trials 38 recruiting studies
Refine in advanced search Browse all conditions

Prostatic Neoplasms trial results

Completed

Study of CP-751,871 in Combination With Docetaxel and Prednisone in Patients With Hormone Insensitive Prostate Cancer (HRPC)

NCT00313781

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +7 more
Locations
  • Pfizer Investigational Site Los Angeles, California, United States
  • Pfizer Investigational Site New York, United States
  • Pfizer Investigational Site Cleveland, Ohio, United States
  • Pfizer Investigational Site Cleveland, Ohio, United States
View all 18 locations
View Trial Details
Completed

A Phase 2 Study to Investigate the Clinical Activity of IPI-504 in Patients With Hormone-resistant Prostate Cancer

NCT00564928

Conditions
Cancer of the Prostate, Genital Diseases, Genital Diseases, Male, +9 more
Locations
  • San Bernardino Urological Associates San Bernardino, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • University of Colorado at Denver Denver, Colorado, United States
  • MCG Cancer Center Augusta, Georgia, United States
View Trial Details
Completed

Clinical Evaluation of the PROGENSA(Registered Trademark) Prostate Cancer Gene 3 (PCA3) Assay in Men With a Previous Negative Biopsy Result

NCT01024959

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +7 more
Locations
  • HealthCare Partners Medical Group Los Angeles, California, United States
  • San Diego Clinical Trials San Diego, California, United States
  • South Florida Medical Research Aventura, Florida, United States
  • Specialists in Urology Naples, Florida, United States
View all 13 locations
View Trial Details

Related conditions